Lv6
2970 积分 2024-01-12 加入
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models
5天前
已完结
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
5天前
已完结
Body-mass index and risk of obesity-related complex multimorbidity:an observational multicohort study
5天前
已完结
Health policy and public health implications of obesity in China
5天前
已完结
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
20天前
已完结
Associations between Class I, II, or III Obesity and Health Outcomes
1个月前
已完结
Advances and challenges in kidney fibrosis therapeutics
2个月前
已完结
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
2个月前
已完结
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism
2个月前
已完结
Long-Term Outcome of Anti–Glomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression
5个月前
已完结
皖公网安备34019202002308
